Seven teenage girls from across the country, aged 17 to 22, have died from ALS, a disease primarily affecting the middle-aged. For years, their mothers
A huge thank you to the New York Mets, our corporate sponsors Safway Atlantic, Hallen Steel, TD Securities Investment Banking (USA) LLC, and M&D Millwork, and everyone who came
Women & the Brain scholarship recipient Dr. Mackenzie Mathis of Harvard University has developed DeepLabCut, a groundbreaking AI tool that tracks movement. Women & the
Begun in 2017, the Project ALS Pre-Clinical Core (the Core) is the first rational, aggressive effort to rapidly and thoroughly test promising therapies for safety
The Core is the culmination of 20 years of Project ALS research achievements in genetics, stem cell research, and basic research studies. These breakthroughs allow
It is highly unlikely that a cure for ALS disease will come until we understand more about brain development, motor behavior and circuitry. Project ALS
Project ALS was the first organization to use stem cells to model human ALS; this practice is now used worldwide. Project ALS scientists also use patient stem cells to screen for drugs.
Uplifting Athletes will honor Project ALS-funded Columbia University researcher Emily Lowry, PhD, with one of its first five Young Investigator Awards. Uplifting Athletes, a nonprofit
Alejandro Garcia, who began working with Project ALS in 2009 as a research technician, and eventually lab manager of the Jenifer Estess Stem Cell Lab
Meet Elizabeth Adelson, a neuroscience student at Yale University whom Project ALS will sponsor this summer, along with 4 other students, for a research internship
Named in honor of former Project ALS board member and inspiration Tom Kirchhoff, the Tom Kirchhoff Family Post-Doctoral Fellowship at Project ALS is given to
An exciting Project-ALS funded study on the involvement of the gene TDP-43 in ALS-frontotemporal dementia. Understanding how TDP-43 contributes to neurodegeneration will help direct therapeutic
